114 related articles for article (PubMed ID: 4993126)
1. Nicotinic acid as an adjuvant in the treatment of chronic schizophrenic patients with special reference to changes in higher nervous activity.
Saarma J; Vasar H
Curr Ther Res Clin Exp; 1970 Nov; 12(11):729-33. PubMed ID: 4993126
[No Abstract] [Full Text] [Related]
2. Nicotinic acid in the treatment of newly admitted schizophrenic patients: a placebo-controlled study.
Ananth JV; Vacaflor L; Kekhwa G; Sterlin C; Ban TA
Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):406-10. PubMed ID: 4261601
[No Abstract] [Full Text] [Related]
3. Nicotinic acid in the treatment of chronic hospitalized schizophrenic patients: a placebo-controlled clinical study.
Deutsch M; Ananth JV; Ban TA
Psychopharmacol Bull; 1977 Jul; 13(3):21-3. PubMed ID: 142260
[No Abstract] [Full Text] [Related]
4. Neuroleptic therapy for chronic schizophrenia.
Ayd FJ
Dis Nerv Syst; 1972 Jan; 33(1):35-9. PubMed ID: 5059687
[No Abstract] [Full Text] [Related]
5. [Use of nicotinic acid in the treatment of chronic schizophrenia].
Maslowski J
Psychiatr Pol; 1967; 1(3):307-11. PubMed ID: 5593258
[No Abstract] [Full Text] [Related]
6. Nicotinic acid as adjuvant therapy in newly admitted schizophrenic patients.
Ramsay RA; Ban TA; Lehmann HE; Saxena BM; Bennett J
Can Med Assoc J; 1970 May; 102(9):939-42. PubMed ID: 4157149
[TBL] [Abstract][Full Text] [Related]
7. Influence of treatment with an amino oxidase inhibitor on the excretion of bufotenin and the clinical symptoms in chronic schizophrenic patients.
Heller B
Int J Neuropsychiatry; 1966 Apr; 2(2):193-203. PubMed ID: 5959966
[No Abstract] [Full Text] [Related]
8. The serum urate level reflects degree of stress.
Pfeiffer CC; Iliev V; Nichols RE; Sugerman AA
J Clin Pharmacol J New Drugs; 1969; 9(6):384-92. PubMed ID: 5260201
[No Abstract] [Full Text] [Related]
9. Drug management in chronic schizophrenia.
Tune LE; McHugh PR; Coyle JT
Johns Hopkins Med J; 1982 Jan; 150(1):45-8. PubMed ID: 7054584
[No Abstract] [Full Text] [Related]
10. Comparison of trifluoperazine and molindone in chronic schizophrenic patients.
Freeman H; Frederick AN
Curr Ther Res Clin Exp; 1969 Nov; 11(11):670-6. PubMed ID: 4982301
[No Abstract] [Full Text] [Related]
11. Acute paranoid schizophrenia. (Treatment with chlorpromazine, trifluoperazine and placebo).
Reardon JD; Abrams S
Dis Nerv Syst; 1966 Apr; 27(4):265-70. PubMed ID: 5936140
[No Abstract] [Full Text] [Related]
12. [Comparative study of trifluperidol and trifluoperazine in the treatment of acute schizophrenia].
Gauthier R; Hillel J; Bordeleau JM; Tétreault L
Union Med Can; 1967 Aug; 96(8):936-43. PubMed ID: 5618135
[No Abstract] [Full Text] [Related]
13. [Predicting the effect of psychopharmacotherapy in schizophrenic patients].
Dikiĭ NT
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):110-5. PubMed ID: 6121436
[TBL] [Abstract][Full Text] [Related]
14. Molindone: a controlled evaluation in chronic schizophrenic patients.
Gallant DM; Bishop MP
Curr Ther Res Clin Exp; 1968 Sep; 10(9):441-7. PubMed ID: 4971648
[No Abstract] [Full Text] [Related]
15. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
Wilson LG; Roberts RW; Gerber CJ; Johnson MH
J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441
[TBL] [Abstract][Full Text] [Related]
16. Comparison of trifluperidol, trifluoperazine and chlorpromazine in preschool schizophrenic children: the value of less sedative antipsychotic agents.
Fish B; Campbell M; Shapiro T; Floyd A
Curr Ther Res Clin Exp; 1969 Oct; 11(10):589-95. PubMed ID: 4981301
[No Abstract] [Full Text] [Related]
17. Qualitative and quantitative EEG changes of intramuscular thiothixene and trifluoperazine in chronic schizophrenia.
Akpinar S; Itil TM; Holden JM; Hsu W
Dis Nerv Syst; 1972 Jan; 33(1):40-5. PubMed ID: 5059688
[No Abstract] [Full Text] [Related]
18. A study of the withdrawal of chlorpromazine or trifluoperazine in chronic schizophrenia.
Morton MR
Am J Psychiatry; 1968 May; 124(11):1585-8. PubMed ID: 4869439
[No Abstract] [Full Text] [Related]
19. [Results of glucose tolerance tests and changes in inorganic serum phosphate and potassium levels in schizophrenic patients responding to treatment with psychotropic drugs].
Máthé V; Kassay G; Tüske M
Int Pharmacopsychiatry; 1971; 6(2):111-30. PubMed ID: 4147757
[No Abstract] [Full Text] [Related]
20. Metiapine: a double-blind evaluation in chronic schizophrenic patients.
Gallant DM; Bishop MP; Guerrero-Figueroa R
Curr Ther Res Clin Exp; 1971 Dec; 13(12):734-6. PubMed ID: 5001741
[No Abstract] [Full Text] [Related]
[Next] [New Search]
